Russell Investments Group, Ltd. Glycomimetics Inc Transaction History

Russell Investments Group, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	SELL	$2.89 - $4.22 $260,649 - $380,601	-90,190 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$2.69 - $4.24 $226,323 - $356,732	84,135 Added 1389.51%	90,190 $338,000
Q3 2020 Nov 09, 2020	SELL	$3.07 - $5.0 $50,041 - $81,500	-16,300 Reduced 72.91%	6,055 $18,000
Q2 2020 Aug 05, 2020	BUY	$2.06 - $3.76 $46,051 - $84,054	22,355 New	22,355 $83,000

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.3M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.